Actively Recruiting
Patients With Tuberculosis, Mycobacteriosis or Latent Tuberculosis
Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2025-01-08
13000
Participants Needed
1
Research Sites
262 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In the last 30 years, tuberculosis (TB) has re-emerged in industrialised countries as a public health, with a decrease in incidence among the resident population and an increase in the burden of immigrants. Therefore, it becomes a priority to implement an effective TB control that relies on both rapid and reliable identification of active infections, with a adequate treatment and surveillance of resistance, but also on the identification of latent tuberculosis infections (ITBL) in populations at higher risk of progression to the active disease, representing a source of infection for the community.
CONDITIONS
Official Title
Patients With Tuberculosis, Mycobacteriosis or Latent Tuberculosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age of 18 years or more
- Clinical or radiological suspicion of tuberculosis, non-tubercular mycobacteriosis, or latent tuberculosis infection
- Sent at least one biological sample for mycobacteria testing or a blood sample for the IGRA test to the Microbiology laboratory
- Provided informed consent to participate
You will not qualify if you...
- None
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Italy, 40138
Actively Recruiting
Research Team
P
Paola Dal Monte, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here